switching from liraglutide to semaglutide MCT2D Switching from liraglutide to semaglutide
Description
This class of drugs, originally used for type 2 diabetes, is now widely used for weight loss because the medications curb appetite, slow digestion, and promote weight loss
Glucagon-like peptide-1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP) are metabolic hormones released by our gut after we eat a meal
Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) developed by Novo Nordisk in the 1990s [1]
They took into consideration my full health picture as a perimenopausal woman
Frontiers in Endocrinology, 14, 1218880
Liraglutide, or Victoza, has come off patent in June of 2024 but requires a daily injection instead of weekly
